title: Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy.
authors.forename: M P
authors.initials: MP
authors.lastname: Carrieri
authors.forename: C
authors.initials: C
authors.lastname: Pradier
authors.forename: P
authors.initials: P
authors.lastname: Piselli
authors.forename: M
authors.initials: M
authors.lastname: Piche
authors.forename: E
authors.initials: E
authors.lastname: Rosenthal
authors.forename: P
authors.initials: P
authors.lastname: Heudier
authors.forename: J
authors.initials: J
authors.lastname: Durant
authors.forename: Diego
authors.initials: D
authors.lastname: Serraino
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D015497:HIV-1; D006801:Humans; D015994:Incidence; D008137:Longitudinal Studies; D016483:Lymphoma, AIDS-Related / Q000453:epidemiology* / Q000517:prevention & control; D008228:Lymphoma, Non-Hodgkin / Q000453:epidemiology* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D012514:Sarcoma, Kaposi / Q000453:epidemiology* / Q000517:prevention & control
chemical_list: D019380:Anti-HIV Agents